LINC-PINT and breast cancer: In addition, LINC-PINT suppresses the genesis of non-small cell lung cancer (NSCLC) as the miR-218-5p sponge through MAFG-AS1, and modulates miR-339-5p expression to promote breast cancer (BC) aggressiveness (Zhang L. et al., 2019).